Breast lesion excision sample (BLES biopsy) combining stereotactic biopsy and radiofrequency: is it a safe and accurate procedure in case of BIRADS 4 and 5 breast lesions?

Détails

ID Serval
serval:BIB_263A5A2C41F5
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Breast lesion excision sample (BLES biopsy) combining stereotactic biopsy and radiofrequency: is it a safe and accurate procedure in case of BIRADS 4 and 5 breast lesions?
Périodique
Breast J
Auteur(s)
Medjhoul A., Canale S., Mathieu M. C., Uzan C., Garbay J. R., Dromain C., Balleyguier C.
ISSN-L
1524-4741 (Electronic)1075-122X (Linking)
Statut éditorial
Publié
Date de publication
2013
Peer-reviewed
Oui
Volume
19
Numéro
6
Pages
590-4
Langue
anglais
Notes
Medjhoul, AichaCanale, SandraMathieu, Marie-ChristineUzan, CatherineGarbay, Jean-RemiDromain, ClarisseBalleyguier, Corinneeng2013/10/10 06:00Breast J. 2013 Nov-Dec;19(6):590-4. doi: 10.1111/tbj.12184. Epub 2013 Sep 19.
Résumé
The aim of this study was to evaluate the accuracy and safety of breast lesion excision system (BLES) procedure with an Intact system device, under stereotactic and ultrasound guidance. Retrospective data review of 32 breast lesions BI-RADS 4 or 5 underwent Intact procedures, from March 2010 to January 2012. Underestimation rates of atypical ductal hyperplasia (ADH) and ductal carcinoma in situ (DCIS) were evaluated; percentage of complete radiologic and histologic removal of the breast lesion were analyzed, as were the complications due to procedure. Complete radiologic excision of the target lesion was achieved in all masses and 58.6% of calcifications. Lesion size was less than 11 mm (mean size 5.6 mm). Underestimation of ADH and DCIS was 0% and 10%, respectively. Low complication rate was noted: only one hematoma. BLES appears an accurate and safe biopsy system for sampling nonpalpable breast lesions, especially in case of microcalcifications clusters categorized as BI-RADS 4 and 5.
Mots-clé
Biopsy/*methods, Breast/*pathology, Breast Neoplasms/*pathology, Carcinoma, Intraductal, Noninfiltrating/pathology, Female, Humans, Hyperplasia, Middle Aged, Retrospective Studies, *Stereotaxic Techniques
Création de la notice
16/09/2016 10:14
Dernière modification de la notice
20/08/2019 13:04
Données d'usage